- pause slideshow
An expert working group of the UK’s Commission on Human Medicines, a committee within the Medicines and Healthcare products Regulatory Agency, has launched a review looking into the risks and benefits of opioid medicines.
Exclusive: The chair of the General Pharmaceutical Council (GPhC) has said he is “concerned” that planned cuts to preregistration training could make it more difficult to ensure that pharmacists can meet the changing demands of the NHS.
The opioid antagonist naltrexone does not appear to increase the risk of serious adverse events over placebo, researchers from the University of Manchester have found.
A previously identified link between antidepressant use and hip fractures needs further examination, the authors of a study published in JAMA Psychiatry have concluded.
Monthly dosing of vitamin D3 supplements in older adults does not increase bone mineral density, the results of a recent study show.
A post-myocardial infarction medicines optimisation clinic, led primarily by a pharmacist with support from a cardiologist, has resulted in improved medicines adherence and guideline concordance, study results published in Open Heart show.
There is a lack of evidence that medicines for osteoarthritis are effective in the long term, according to a review in the Journal of the American Medical Association.
Sulfonylureas and basal insulin confer an increased risk of cardiovascular events compared with newer second-line medicines for type 2 diabetes mellitus, research has found.
A major initiative by pharmacists to reduce risky medicines use in the community will be rolled out across the country after it was found to reduce serious adverse events.
Wrightington, Wigan and Leigh NHS Foundation Trust has dramatically improved medicines safety through pharmacy-led initiatives to address mistakes in prescribing and improve error reporting.
Two years on from Lord Carter’s 2016 review of hospital efficiency, The Salvadore looks at the progress pharmacy departments in England are making towards meeting his challenging targets.
Follow the latest updates on the proposed 12% funding cuts to community pharmacy, which could result in the closure of a quarter of pharmacies in England.